Skip to content

There are now estimated to be more than 100,000 medical cannabis patients in the UK. Find out if you qualify

  • Patient Guide
Medical Cannabis Patients Hub
  • About
  • Patient Guide
  • Conditions
  • Articles
  • Strains
  • Cannabinoids
  • Terpenes
  • Contact
Menu
  • About
  • Patient Guide
  • Conditions
  • Articles
  • Strains
  • Cannabinoids
  • Terpenes
  • Contact

Indica vs sativa: what prescribed patients should know

Indica vs sativa: what prescribed patients should know — MCPH article cover
Facebook-f Twitter Youtube Linkedin-in

Table of Contents

MCPH Editorial TeamPublished 22 August 2026Updated 22 August 2026How MCPH maintains contentReport a correction

Home
»
Conditions and Symptoms
»
Indica vs sativa: what prescribed patients should know

Indica and sativa began as botanical labels

The terms Cannabis sativa and Cannabis indica have a long botanical history. Modern commercial cannabis has been heavily crossed, while product language often uses “indica”, “sativa” and “hybrid” as broad market categories.

That market shorthand is different from a measured chemical profile.

What the labels do not reliably predict

An indica or sativa label does not provide:

  • THC or CBD concentration
  • a complete terpene profile
  • batch consistency
  • a guaranteed sedating or stimulating effect
  • a condition-specific clinical outcome

Products carrying different category labels can have similar chemistry, and products with the same label can differ materially.

What describes a product more clearly

The dispensing label gives the prescribed strength and product identity. A certificate of analysis may add minor cannabinoid, terpene and batch information. Dose and route then affect the exposure.

These details do not predict an individual response perfectly, but they are measurable. “Indica for night” and “sativa for day” are not equivalent to clinical evidence.

Why the shortcut persists

The two-category system is easy to remember and appears throughout cannabis culture, retail menus and patient conversations. Reviewers may also report recurring patterns within a familiar product. Those experiences can be useful as personal records, but expectation, dose, setting and prior exposure all influence them.

Comparing two prescribed products

Compare the producer, batch, THC, CBD, route, prescribed amount and timing. If terpene data is available, treat it as another measured feature rather than a promise of effect.

A previous response to a product with the same cultivar name may be relevant history. It does not prove that another producer’s version has the same composition.

The clinical evidence gap

Clinical trials test defined preparations and doses. They do not establish indica and sativa as treatment categories. Botanical and chemotaxonomic papers also show why cultivar and species labels cannot stand in for chemical analysis.

Read next

  • How to read a strain page on MCPH and Strains
  • What are terpenes in medical cannabis?
  • THC:CBD ratios explained

Sources

  1. Small E. Evolution and classification of Cannabis sativa in relation to human utilization. The Botanical Review. 2015. Study record
  2. Piomelli D, Russo EB. The Cannabis sativa versus Cannabis indica debate: an interview with Ethan Russo, MD. Cannabis and Cannabinoid Research. 2016. Study record
  3. McPartland JM. Cannabis systematics at the levels of family, genus, and species. Cannabis and Cannabinoid Research. 2018. Study record
  4. Elzinga S, et al. Cannabinoids and terpenes as chemotaxonomic markers in cannabis. Natural Products Chemistry and Research. 2015. Study record
Author picture

Read the eligibility guide for medical cannabis in the UK

Read the eligibility guide

Click here
  • Useful patient resources

New to prescribed cannabis?

Start with the Patient Guide →

Understand the UK route

  • Articles, glossary and clinic explainers

Cannabis Patient Eligibility Checker

  • Check whether you may qualify

© Medical Cannabis Patients Hub 2026. All rights reserved.

  • Facebook Group
  • X
PrivacyMedical DisclaimerEditorial PolicyTermsAccessibilityCorrectionsCookies